Search - tctmd.com

Displaying 1 - 20 of 172

Sort: Relevancy | Date

News Conference News TCT 2025

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

Caitlin E. Cox

October 28, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Presentation TCT 2024

TCT 681: Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Non-Significant Obstructive Coronary Artery Disease

Presenter: Shoichi Kuramitsu

October 30, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

Modulation of Antiplatelet Therapy After PCI

Presenter: Michelle O'Donoghue

October 28, 2024

Presentation TCT 2024

TCT 9: Diagnostic Accuracy of CT-FFR and QFR for Coronary Lesion-Specific Ischemia

Presenter: Haoyu Wu

October 27, 2024

Presentation TCT 2024

TCT 11: Inpatient Outcomes of Non-ST-Elevation Myocardial Infarction Patients on Chronic Anticoagulation: A Nationwide Analysis

Presenter: Ahmed Younes

October 27, 2024

Presentation TCT 2024

TCT 7: Impact of Use of Proton Pump Inhibitor in Patients Taking Clopidogrel: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mobeen Haider

October 27, 2024

Presentation TCT 2024

TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT

Presenter: Victor Alfonso Jimenez Diaz

October 27, 2024

Presentation TCT 2024

TCT 10: Interference of Fentanyl in the Pharmacodynamics and Pharmacokinetics of Ticagrelor: A Meta-Analysis of Randomized Trials

Presenter: BERNARDO KREMER

October 27, 2024

Presentation TCT 2024

TCT 289: Different Efficacy of 12-Month Dual Antiplatelet Therapy Following Off-Pump Versus On-Pump Coronary Artery Bypass Grafting

Presenter: Woo Jin Jang

October 27, 2024

Presentation TCT 2024

TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry

Presenter: Niels van der Sangen

October 27, 2024

Presentation TCT 2024

TCT 401: Impact of >12-Month Versus =12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention

Presenter: Yao Jiang

October 27, 2024

Presentation TCT 2024

TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

Presenter: IFTIKHAR CH

October 27, 2024

Presentation TCT 2024

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presenter: Mauro Gitto

October 27, 2024

Presentation TCT 2024

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

Presenter: Jung-Kyu Han

October 27, 2024

Presentation TCT 2024

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

Presenter: KOTARO MIYASHITA

October 27, 2024

Presentation TCT 2024

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

Presenter: Angelo Oliva

October 27, 2024

Advertisement

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

What’s Going to Be Hot at TCT 2025

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

TCT 681: Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Non-Significant Obstructive Coronary Artery Disease

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Modulation of Antiplatelet Therapy After PCI

TCT 9: Diagnostic Accuracy of CT-FFR and QFR for Coronary Lesion-Specific Ischemia

TCT 11: Inpatient Outcomes of Non-ST-Elevation Myocardial Infarction Patients on Chronic Anticoagulation: A Nationwide Analysis

TCT 7: Impact of Use of Proton Pump Inhibitor in Patients Taking Clopidogrel: A Meta-Analysis of Randomized Controlled Trials

TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT

TCT 10: Interference of Fentanyl in the Pharmacodynamics and Pharmacokinetics of Ticagrelor: A Meta-Analysis of Randomized Trials

TCT 289: Different Efficacy of 12-Month Dual Antiplatelet Therapy Following Off-Pump Versus On-Pump Coronary Artery Bypass Grafting

TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry

TCT 401: Impact of >12-Month Versus =12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention

TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content